{"SPADE_N_14717": {"Sequence Information": {"Peptide Name": "Longicalycinin A", "Sequence": "FYPFG", "Sequence Length": 5, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Antifungal", "Anti-Mammalian Cell", "Nematode"], "Binding Target": "1. Lysosomal membrane", "Source": "1. Dianthus superbus", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Synthetic and pharmacological studies on longicalycinin A.", "Pubmed ID": "17604256", "Reference": "Pak J Pharm Sci. 2007;20:317-323", "Author": "Dahiya R", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/17604256"}, {"Title": "Solid-phase total synthesis of cyclic pentapeptide Longicalycinin A, by using 2-chlorotrityl chloride resin", "Pubmed ID": "", "Reference": "J Cancer Res Exp Oncol. 2013;5:8-19", "Author": "Ahmad W", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/"}, {"Title": "Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides.", "Pubmed ID": "31747558", "Reference": "Chem Biol Interact. 2020;315:108902", "Author": "Gholibeikian M, Bamoniri A, HoushdarTehrani MH, Fatemeh Mirjalili BB, Bijanzadeh HR", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/31747558"}], "Mass": 629.7, "PI": 5.52, "Net Charge": 0, "Hydrophobicity": 0.46, "Frequent Amino Acids": "FGP", "Absent Amino Acids": "ACDEHIKLMNOQRSTUVW", "Basic Residues": 0, "Acidic Residues": 0, "Hydrophobic Residues": 2, "Polar Residues": 3, "Positive Residues": 0, "Negative Residues": 0, "SPADE ID": "SPADE_N_14717", "Similar Sequences": [{"SPADE_ID": "SPADE_N_12875", "Similarity": 1.0, "Sequence": "RFRPPIRRPPIRPPFYP"}, {"SPADE_ID": "SPADE_UN_15561", "Similarity": 1.0, "Sequence": "RFRRPIRRRPIRPPFYP"}, {"SPADE_ID": "SPADE_UN_15567", "Similarity": 1.0, "Sequence": "RFRWPIRRRPIRPPFYP"}], "Hemolytic Activity": "Human skin fibroblasts:71.47% Cell death=100 µg/ml", "Target Organism": "Bacillus subtilis MUMC 408(no activity data),Staphylococcus aureus MUMC 377(no activity data),Pseudomonas aeruginosa MUMC 266(MIC=12.5µg/ml),Escherichia coli MUMC 106(MIC=12.5µg/ml),Candida albicans MUMC 29(no activity data),Microsporum audouinii MUMC 545(MIC=6µg/ml),Aspergillus niger MUMC 77(MIC=12.5µg/ml),Trichophyton mentagrophytes MUMC 665(MIC=6µg/ml),Dalton's lymphoma ascites(IC50=2.62µM),Ehrlich's ascites carcinoma(IC50=6.37µM),Megascolex konkanensis(LD=2000µg/ml),Pontoscolex corethrurus(LD=2000µg/ml),Eudrilus eugeniae(LD=2000µg/ml),Human hepatocellular carcinoma HepG2(IC50=13.52µg/ml),Dalton's lymphoma ascites(IC50=2.62µM),Ehrlich's ascites carcinoma(IC50=6.17µM),Human colon adenocarcinoma HT29(IC50=11.87±0.0021µg/ml)"}}}